This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 May;5(5):489-90.

doi: 10.1038/8371.

Thalidomide on the comeback trail

PMID: 10229222
DOI: 10.1038/8371

Comment

Thalidomide on the comeback trail

B F Hales. Nat Med. 1999 May.

. 1999 May;5(5):489-90.

doi: 10.1038/8371.

Author

PMID: 10229222
DOI: 10.1038/8371

No abstract available

PubMed Disclaimer

Comment on

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
Parman T, Wiley MJ, Wells PG. Parman T, et al. Nat Med. 1999 May;5(5):582-5. doi: 10.1038/8466. Nat Med. 1999. PMID: 10229238

Similar articles

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
Parman T, Wiley MJ, Wells PG. Parman T, et al. Nat Med. 1999 May;5(5):582-5. doi: 10.1038/8466. Nat Med. 1999. PMID: 10229238
[Thalidomide: a review of the literature].
dos Santos Júnior MF, Lombardi C, Belda W. dos Santos Júnior MF, et al. Hansenol Int. 1981 Dec;6(2):136-45. Hansenol Int. 1981. PMID: 7349301 Portuguese. No abstract available.
[Thalidomide: new uses for an old drug].
Wu KL, Sonneveld P. Wu KL, et al. Ned Tijdschr Geneeskd. 2002 Aug 3;146(31):1438-41. Ned Tijdschr Geneeskd. 2002. PMID: 12190008 Review. Dutch.
The rehabilitation of thalidomide.
MacDougall DS. MacDougall DS. J Int Assoc Physicians AIDS Care. 1998 Jan;4(1):26-33. J Int Assoc Physicians AIDS Care. 1998. PMID: 11365029
Hypothesis: thalidomide embryopathy-proposed mechanism of action.
Stephens TD, Fillmore BJ. Stephens TD, et al. Teratology. 2000 Mar;61(3):189-95. doi: 10.1002/(SICI)1096-9926(200003)61:3<189::AID-TERA6>3.0.CO;2-W. Teratology. 2000. PMID: 10661908 Review.

See all similar articles

Cited by

Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide.
Furihata H, Yamanaka S, Honda T, Miyauchi Y, Asano A, Shibata N, Tanokura M, Sawasaki T, Miyakawa T. Furihata H, et al. Nat Commun. 2020 Sep 14;11(1):4578. doi: 10.1038/s41467-020-18488-4. Nat Commun. 2020. PMID: 32929090 Free PMC article.
Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells.
Marriott JB, Clarke IA, Dredge K, Muller G, Stirling D, Dalgleish AG. Marriott JB, et al. Clin Exp Immunol. 2002 Oct;130(1):75-84. doi: 10.1046/j.1365-2249.2002.01954.x. Clin Exp Immunol. 2002. PMID: 12296856 Free PMC article. Clinical Trial.
Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006.
Cronin-Fenton DP, Søndergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, Baron JA, Sørensen HT. Cronin-Fenton DP, et al. Br J Cancer. 2010 Sep 28;103(7):947-53. doi: 10.1038/sj.bjc.6605883. Epub 2010 Sep 14. Br J Cancer. 2010. PMID: 20842120 Free PMC article.
Angiogenesis inhibitors in lung cancer.
Kim ES, Herbst RS. Kim ES, et al. Curr Oncol Rep. 2002 Jul;4(4):325-33. doi: 10.1007/s11912-002-0008-0. Curr Oncol Rep. 2002. PMID: 12044242 Review.
Management of thalidomide toxicity.
Ghobrial IM, Rajkumar SV. Ghobrial IM, et al. J Support Oncol. 2003 Sep-Oct;1(3):194-205. J Support Oncol. 2003. PMID: 15334875 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group